na-931 vs retatrutide vs. Tirzepatide: The New Contender vs. the Current Leader Impact of incretin analogues on
Description
2019, Harvard Health Publishing
Russo GT, De Cosmo S, Viazzi F, et al
The risk of adverse event development depends on the prior therapy, the duration of the treatment, the form of the drug, and individual factors, i.e., BMI, genetics, and age
Most pass in hours or a few days
For psychiatrists not already comfortable with metabolic monitoring, this requires developing new skills
Drug therapy in obesity: a review of current and emerging treatments
